Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 2 (2017), Article ID 2:IJCPP-130, 3 pages
https://doi.org/10.15344/2456-3501/2017/130
Commentary
Modulation of P-glycoprotein Expression and Function under Disease States in Rats and Humans

Teruo Murakami*, Masashi Ishiguro and Keisuke Oda

Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, 5-1-1 Hirokoshingai, Kure, Hiroshima 737-0112, Japan
Prof. Teruo Murakami, Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, 5-1-1 Hirokoshingai, Kure, Hiroshima 737-0112, Japan; E-mail: t-muraka@ps.hirokoku-u.ac.jp
06 December 2017; 12 December 2017; 14 December 2017
Murakami T, Ishiguro M, Oda K (2017) Modulation of P-glycoprotein Expression and Function under Disease States in Rats and Humans. Int J Clin Pharmacol Pharmacother 2: 130. doi: https://doi.org/10.15344/2456-3501/2017/130
© 2017 Murakami et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Murakami T, Takano M (2008) Intestinal efflux transporters and drug absorption. Expert Opin Drug Metab Toxicol 4: 923-939 [CrossRef] [Google Scholar] [PubMed]
  2. https://www.drugs.com/drug-interactions/cyclosporine.html
  3. Turton-Weeks SM, Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, et al. (2001) St John's wort: a hidden risk for transplant patients. Prog Transplant 11:116-120 [CrossRef] [Google Scholar] [PubMed]
  4. Bai JPF, Burckart GJ, Mulberg AE. (2016) Literature Review of Gastrointestinal Physiology in the Elderly, in Pediatric Patients, and in Patients with Gastrointestinal Diseases. J Pharm Sci. 105:476-483 [CrossRef] [Google Scholar] [PubMed]
  5. Huang ZH, Murakami T, Okochi A, Yumoto R, Nagai J, et al. (2000) Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur J Pharmacol 406: 453-460 [CrossRef] [Google Scholar] [PubMed]
  6. Huang ZH, Murakami T, Okochi A, Yumoyo R, Nagai J, et al. (2001) Expression and function of P-glycoprotein in rats with carbon tetrachlorideinduced acute hepatic failure. J Pharm Pharmacol 53: 873-881 [CrossRef] [Google Scholar] [PubMed]
  7. Yumoto R, Murakami T, Takano M (2003) Differential effect of acute hepatic failure on in vivo and in vitro P-glycoprotein functions in the intestine. Pharm Res 20: 765-771 [CrossRef] [Google Scholar] [PubMed]
  8. Murakami T, Yumoto R, Nagai J, Takano M (2002) Factors affecting the expression and function of P-glycoprotein in rats: drug treatments and diseased states. Pharmazie 57:102-107 [Google Scholar] [PubMed]
  9. Dreisbach AW, Lertora JJ (2008) The effect of chronic renal failure on drug metabolism and transport. Expert Opin Drug Metab Toxicol 4: 1065-1074 [CrossRef] [Google Scholar] [PubMed]
  10. Naud J, Michaud J, Leblond FA, Lefrancois S, Bonnardeaux A, et al. (2008) Effects of chronic renal failure on liver drug transporters. Drug Metab Dispos 36: 124-128 [CrossRef] [Google Scholar] [PubMed]
  11. Naud J, Michaud J, Beauchemin S, Hébert MJ, Roger M, et al. (2011) Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats. Drug Metab Dispos 39: 1363-1369 [CrossRef] [Google Scholar] [PubMed]
  12. Naud J, Laurin LP, Michaud J, Beauchemin S, Leblond FA, et al. (2012) Effects of chronic renal failure on brain drug transporters in rats. Drug Metab Dispos 240: 39-46 [CrossRef] [Google Scholar] [PubMed]
  13. Naud J, Michaud J, Boisvert C, Desbiens K, Leblond FA, et al. (2007) Down-regulation of intestinal drug transporters in chronic renal failure in rats. J Pharmacol Exp Ther 320: 978-985 [CrossRef] [Google Scholar] [PubMed]
  14. Sun H, Frassetto L, Benet LZ (2006) Effects of renal failure on drug transport and metabolism. Pharmacol Ther 109:1-11 [CrossRef] [Google Scholar] [PubMed]
  15. Kaplan B, Lown K, Craig R, Abecassis M, Kaufman D, et al. (1999) Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. Transplantation 67:333-335 [CrossRef] [Google Scholar] [PubMed]
  16. Buchman AL, Paine MF, Wallin A, Ludington SS (2005) A higher dose requirement of tacrolimus in active Crohn's disease may be related to a high intestinal P-glycoprotein content. Dig Dis Sci 50: 2312-2315 [CrossRef] [Google Scholar] [PubMed]
  17. Fakhoury M, Lecordier J, Medard Y, Peuchmaur M, Jacqz-Agrain E (2006) Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease. Inflamm Bowel Dis 12:745- 749 [CrossRef] [Google Scholar] [PubMed]
  18. Englund G, Jacobson A, Rorsman F, Artursson P, Kindmark A, et al. (2007) Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflamm Bowel Dis 13: 291-297 [CrossRef] [Google Scholar] [PubMed]
  19. Gutmann H, Hruz P, Zimmermann C, Straumann A, Terracciano L, et al. (2008) Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls. Digestion 78: 154-162 [CrossRef] [Google Scholar] [PubMed]
  20. Westerlund M, Belin AC, Olson L, Galter D (2008) Expression of multidrug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients. Cell Tissue Res 334: 179-185 [CrossRef] [Google Scholar] [PubMed]
  21. Ufer M, Häsler R, Jacobs G, Haenisch S, Lächelt S, et al. (2009) Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity. Pharmacogenomics 10: 1941-1953 [CrossRef] [Google Scholar] [PubMed]
  22. Blokzijl H, Vander Borght S, Bok LI, Libbrecht L, Geuken M, et al. (2007) Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm Bowel Dis 13: 710-720 [CrossRef] [Google Scholar] [PubMed]
  23. Provenzani A, Notarbartolo M, Labbozzetta M, Poma P, Vizzini G, et al. (2011) Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. Int J Mol Med 28: 1093-1102 [CrossRef] [Google Scholar] [PubMed]
  24. Zhang YJ, Xu JJ, Wang P, Wang JL (2014) Multidrug resistance gene and its relationship to ulcerative colitis and immune status of ulcerative colitis. Genet Mol Res 13: 10837-10851 [CrossRef] [Google Scholar] [PubMed]
  25. Andersen V, Vogel U, Godiksen S, Frenzel FB, Sæbø M, et al. (2013) Low ABCB1 gene expression is an early event in colorectal carcinogenesis. PLoS One 8: e72119 [CrossRef] [Google Scholar] [PubMed]
  26. Andersen V, Vogel LK, Kopp TI, Sæbø M, Nonboe AW, et al (2015) High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence. PLoS One 10: e0119255 [CrossRef] [Google Scholar] [PubMed]
  27. Hashida T, Masuda S, Uemoto S, Saito H, Tanaka K, et al. (2001) Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin Pharmacol Ther 69: 308-316 [CrossRef] [Google Scholar] [PubMed]
  28. Masuda S, Goto M, Kiuchi T, Uemoto S, Kodawara T, et al. (2003) Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation. Liver Transpl 9: 1108-1113 [CrossRef] [Google Scholar] [PubMed]
  29. Masuda S, Goto M, Okuda M, Ogura Y, Oike F, et al. (2005) Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients. Transplant Proc 37: 1728- 1729 [CrossRef] [Google Scholar] [PubMed]
  30. Sharaki O, Zeid M, Moez P, Zakaria NH, Nassar E (2015) Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients. Mol Biol Rep 42: 105-117 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.